Endothelial-adipocyte Cx43 Mediated Gap Junctions Can Regulate Adiposity
Function · 2024
DOI: 10.1093/function/zqae029 ↗At a glance
Journal article in Function, 2024. Written by Melissa A Luse and 9 co-authors. Institution: Robert M. Berne Cardiovascular Research Center, University of Virginia School of Medicine, Charlottesville, 22903, VA, USA. Major MEDLINE topics: Adipocytes, Adiposity, Connexin 43, Endothelial Cells. Cited 3 times so far (Crossref); 42 references. The full text is freely available (open access, CC BY 4.0). Funded by: Lipedema Foundation, NHLBI NIH HHS, University of Virginia.
Abstract (original language)
Obesity is a multifactorial metabolic disorder associated with endothelial dysfunction and increased risk of cardiovascular disease. Adipose capillary adipose endothelial cells (CaECs) plays a crucial role in lipid transport and storage. Here, we investigated the mechanisms underlying CaEC-adipocyte interaction and its impact on metabolic function. Single-cell RNA sequencing (scRNAseq) revealed an enrichment of fatty acid handling machinery in CaECs from high fat diet (HFD) mice, suggesting their specialized role in lipid metabolism. Transmission electron microscopy (TEM) confirmed direct heterocellular contact between CaECs and adipocytes. To model this, we created an in vitro co-culture transwell system to model the heterocellular contact observed with TEM. Contact between ECs and adipocytes in vitro led to upregulation of fatty acid binding protein 4 in response to lipid stimulation, hinting intercellular signaling may be important between ECs and adipocytes. We mined our and others scRNAseq datasets to examine which connexins may be present in adipose capillaries and adipocytes and consistently identified connexin 43 (Cx43) in mouse and humans. Genetic deletion of endothelial Cx43 resulted in increased epididymal fat pad (eWAT) adiposity and dyslipidemia in HFD mice. Consistent with this observation, phosphorylation of Cx43 at serine 368, which closes gap junctions, was increased in HFD mice and lipid-treated ECs. Mice resistant to this post-translational modification, Cx43S368A, were placed on an HFD and were found to have reduced eWAT adiposity and improved lipid profiles. These findings suggest Cx43-mediated heterocellular communication as a possible regulatory mechanism of adipose tissue function.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Robert M. Berne Cardiovascular Research Center, University of Virginia School of Medicine, Charlottesville, 22903, VA, USA.
- Department of Molecular Physiology and Biophysics, University of Virginia School of Medicine, Charlottesville, 22903, VA, USA.
- The Fralin Biomedical Research Institute at Virginia Tech Carilion, Center for Vascular and Heart Research, Roanoke, 24016, VA, USA.
- Department of Pharmacology, University of Virginia School of Medicine, Charlottesville, 22903, VA, USA.
- Department of Cell Biology, University of Virginia School of Medicine, Charlottesville, 22903, VA, USA.
ORCID profiles: Brant E Isakson
Funding
- Lipedema Foundation
- NHLBI NIH HHS
- University of Virginia
- NIH HHS
- National Institutes of Health
Cite
APA
Luse, M. A., Dunaway, L. S., Nyshadham, S., Carvalho, A., Sedovy, M. W., Ruddiman, C. A., Tessema, R., Hirschi, K., Johnstone, S. R., & Isakson, B. E. (2024). Endothelial-adipocyte Cx43 Mediated Gap Junctions Can Regulate Adiposity. Function. https://doi.org/10.1093/function/zqae029
Vancouver
Luse MA, Dunaway LS, Nyshadham S, Carvalho A, Sedovy MW, Ruddiman CA, et al. Endothelial-adipocyte Cx43 Mediated Gap Junctions Can Regulate Adiposity. Function. 2024. doi:10.1093/function/zqae029
BibTeX
@article{Luse2024,
author = {Luse, Melissa A and Dunaway, Luke S and Nyshadham, Shruthi and Carvalho, Alicia and Sedovy, Meghan W and Ruddiman, Claire A and Tessema, Rachel and Hirschi, Karen and Johnstone, Scott R and Isakson, Brant E},
title = {Endothelial-adipocyte Cx43 Mediated Gap Junctions Can Regulate Adiposity},
journal = {Function},
year = {2024},
doi = {10.1093/function/zqae029}
}
EUVIMED